ASX 200 morning report – COH, COL & HUB shares in focus
Drew Meredith, CFP
February 23, 2022
Geopolitical concerns sent the S&P/ASX 200 (ASX:XJO) down 1% on
Cochlear Ltd (ASX: COH) is one of the world’s leading medical businesses. Cochlear designs, manufactures and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Graeme Clark invented the first device in 1982, allowing first-user Graham Carrick to hear for the first time for 17 years. Some of the most recent modifications allow users to play sound from their phone directly into their implant.
Geopolitical concerns sent the S&P/ASX 200 (ASX:XJO) down 1% on
The Nanosonics Ltd (ASX: NAN) share price is sinking despite
The Cochlear Limited (ASX: COH) share price has bounced this
In part two of our three-part Australian Investors Podcast mini-series
The Cochlear Limited (ASX:COH) share price is up after providing
The S&P/ASX 200 (ASX: XJO) weakened throughout the day on
The resilient run of the S&P/ASX 200 (ASX: XJO) continued
The S&P/ASX 200 (ASX: XJO) fell another four points on
Despite recording an underlying profit jump 54%, the Cochlear Limited
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
